PRMS
PRMS
批准号:
8468779
负责人:
CARLOS J CARRERA
金额:
$10.82万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2014-04-30
关键词:
Adverse eventCancer CenterCancer Center Support GrantCancer Therapy Evaluation ProgramChargeClinicalClinical ProtocolsClinical ResearchClinical TrialsDataDiseaseEnsureEvaluationFosteringGoalsGrantHealthcare SystemsInstitutionInstitutional Review BoardsMalignant NeoplasmsMonitorMonitoring Clinical TrialsNational Cancer InstitutePatientsPediatric HospitalsPeer ReviewProceduresProtocols documentationRebecca and John Moores UCSD Cancer CenterReportingResearchResourcesReview CommitteeSafetySpecific qualifier valueSystemTimeTranslational ResearchUnited States Department of Veterans AffairsUnited States National Institutes of HealthVeteransanticancer researchauthoritycancer research center directormedical schoolsmeetingsmembermultidisciplinaryresearch study
中文摘要
协议审查监测系统
英文摘要
Protocol Review Monitoring System
The goal of the Protocol Review and Monitoring System (PRMS) is to promote the conduct of scientifically meritorious clinical research under the aegis of the UCSD Cancer Center. The mechanism for accomplishing this is the establishment of a Protocol Review and Monitoring Committee (PRMC). The PRMC is a multidisciplinary standing committee of the Moores Cancer Center. Its charge is the scientific peer review of research studies involving patients with cancer that are conducted at UCSD or its affiliate institutions, the Veterans Administration Healthcare System San Diego and Children's Hospital San Diego. To provide this
oversight function, the PRMC has the following Specific Objectives: (1) perform scientific peer review of cancer-related clinical and translational research protocols to be conducted at UCSD and affiliate institutions; (2) approve a priority designation for new cancer clinical protocols in coordination with leaders of the Cancer Center's disease-focused Specialized Cancer Units; (3) review the scientific progress of active clinical protocols through annual evaluation of subject accrual data; and (4) review in real-time those serious and unexpected adverse events that meet criteria for reporting to the UCSD Institutional Review Board (IRB). The PRMC is granted authority by the Cancer Center Director to approve the initiation and continuation of clinical cancer research protocols, or to recommend their termination according to defined review and monitoring criteria. In concert with these scientific review and monitoring functions, the PRMC directly informs the UCSD IRB of relevant scientific and subject safety issues for complementary review by that committee of cancer-related research submitted for activation at UCSD and affiliate institutions. Both the PRMC Chair and Vice Chair are members of the UCSD IRB, and approval by PRMC is required for the activation of cancer-related research at UCSD and its affiliates. In achieving its scientific review and monitoring objectives, the PRMC ensures that Cancer Center resources are effectively utilized to foster clinical cancer research that is of high scientific quality and importance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--CLINICAL TRIAL PROTOCOL REVIEW/MONITORING SYSTEM
-
批准号:6592164
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:CARLOS J CARRERA
-
依托单位:
CORE--CLINICAL TRIAL PROTOCOL REVIEW/MONITORING SYSTEM
-
批准号:6653307
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:CARLOS J CARRERA
-
依托单位:
CORE--CLINICAL TRIAL PROTOCOL REVIEW/MONITORING SYSTEM
-
批准号:6599281
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:CARLOS J CARRERA
-
依托单位:
CORE--CLINICAL TRIAL PROTOCOL REVIEW/MONITORING SYSTEM
-
批准号:6501424
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2001
-
负责人:CARLOS J CARRERA
-
依托单位:
L ALANOSINE THERAPY FOR MTAP DEFICIENT LUNG CANCER
-
批准号:6118004
-
项目类别:
-
资助金额:$1.46万
-
财政年份:1998
-
负责人:CARLOS J CARRERA
-
依托单位:
L ALANOSINE THERAPY FOR MTAP DEFICIENT LUNG CANCER
-
批准号:6279199
-
项目类别:
-
资助金额:$1.43万
-
财政年份:1997
-
负责人:CARLOS J CARRERA
-
依托单位:
L ALANOSINE THERAPY FOR MTAP DEFICIENT LUNG CANCER
-
批准号:2390895
-
项目类别:
-
资助金额:$13.9万
-
财政年份:1996
-
负责人:CARLOS J CARRERA
-
依托单位:
L ALANOSINE THERAPY FOR MTAP DEFICIENT LUNG CANCER
-
批准号:2112164
-
项目类别:
-
资助金额:$13.41万
-
财政年份:1996
-
负责人:CARLOS J CARRERA
-
依托单位:
MECHANISMS OF PROGRAMMED CELL DEATH IN CHEMOTHERAPY
-
批准号:2096204
-
项目类别:
-
资助金额:$10.78万
-
财政年份:1991
-
负责人:CARLOS J CARRERA
-
依托单位:
MECHANISMS OF PROGRAMMED CELL DEATH IN CHEMOTHERAPY
-
批准号:2096205
-
项目类别:
-
资助金额:$11.89万
-
财政年份:1991
-
负责人:CARLOS J CARRERA
-
依托单位:
MECHANISMS OF PROGRAMMED CELL DEATH IN CHEMOTHERAPY
-
批准号:3460273
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1991
-
负责人:CARLOS J CARRERA
-
依托单位:
MECHANISMS OF PROGRAMMED CELL DEATH IN CHEMOTHERAPY
-
批准号:3460274
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1991
-
负责人:CARLOS J CARRERA
-
依托单位:
MECHANISMS OF PROGRAMMED CELL DEATH IN CHEMOTHERAPY
-
批准号:3460272
-
项目类别:
-
资助金额:$7.01万
-
财政年份:1991
-
负责人:CARLOS J CARRERA
-
依托单位:
TOXICITY OF DNA DAMAGE IN NON-DIVIDING LYMPHOID CELLS
-
批准号:3079594
-
项目类别:
-
资助金额:$5.47万
-
财政年份:1987
-
负责人:CARLOS J CARRERA
-
依托单位:
TOXICITY OF DNA DAMAGE IN NON-DIVIDING LYMPHOID CELLS
-
批准号:3079595
-
项目类别:
-
资助金额:$5.63万
-
财政年份:1987
-
负责人:CARLOS J CARRERA
-
依托单位:
TOXICITY OF DNA DAMAGE IN NON-DIVIDING LYMPHOID CELLS
-
批准号:3079592
-
项目类别:
-
资助金额:$5.64万
-
财政年份:1987
-
负责人:CARLOS J CARRERA
-
依托单位:
Protocol Review and Monitoring System
-
批准号:8530409
-
项目类别:
-
资助金额:$9.53万
-
财政年份:--
-
负责人:CARLOS J CARRERA
-
依托单位:
EFFECTS OF CDA ON MONOCYTE FUNCTION AND PHENOTYPE IN RA
-
批准号:3747936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:CARLOS J CARRERA
-
依托单位:
海外基金